InsidersTradesSigma
Track the Annexin Pharmaceuticals AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Annexin Pharmaceuticals AB (publ) has recorded 4 reports. Market capitalisation: €89.6m. The latest transaction was reported on 16 July 2026 (Purchase). Among the most active insiders: Mikael Lönn. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Annexin Pharmaceuticals AB (publ) is a Swedish pharmaceutical company focused on developing treatments for inflammatory diseases and cardiovascular disorders. It is listed on the Stockholm Stock Exchange (XSTO).